相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
Zerui Wang et al.
JAMA NEUROLOGY (2021)
Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling
Agnese Petrera et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease
Sara Hall et al.
MOVEMENT DISORDERS (2021)
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
Ahmed Al-Qassabi et al.
MOVEMENT DISORDERS (2021)
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
Alexis Moscoso et al.
JAMA NEUROLOGY (2021)
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
Alex Iranzo et al.
LANCET NEUROLOGY (2021)
Rapid Progress Toward Reliable Blood Tests for Alzheimer Disease
Elisabeth H. Thijssen et al.
JAMA NEUROLOGY (2021)
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
Ondrej Libiger et al.
ALZHEIMERS & DEMENTIA (2021)
Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias
Erica Howard et al.
NEUROLOGY (2021)
In Vivo Diagnosis of Synucleinopathies
Vincenzo Donadio et al.
NEUROLOGY (2021)
Consistent skin α-synuclein positivity in REM sleep behavior disorder-A two center two-to-four-year follow-up study
K. Doppler et al.
PARKINSONISM & RELATED DISORDERS (2021)
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies
Connor Bargar et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Cutaneous α-synuclein is correlated with autonomic impairment in isolated rapid eye movement sleep behavior disorder
Mitchell G. Miglis et al.
SLEEP (2021)
In Vivo Diagnosis of Synucleinopathies A Comparative Study of Skin Biopsy and RT-QuIC
Vincenzo Donadio et al.
NEUROLOGY (2021)
Cutaneous alpha-synuclein is correlated with autonomic impairment in isolated rapid eye movement sleep behavior disorder
Mitchell G. Miglis et al.
SLEEP (2021)
α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients
Sireesha Manne et al.
MOVEMENT DISORDERS (2020)
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies
Marcello Rossi et al.
ACTA NEUROPATHOLOGICA (2020)
Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study
Frank de Wolfa et al.
BRAIN (2020)
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
M. van de Beek et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
Nicolas R. Barthelemy et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Nicholas J. Ashton et al.
NATURE REVIEWS NEUROLOGY (2020)
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
David J. Irwin et al.
ANNALS OF NEUROLOGY (2020)
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease
Niklas Mattsson-Carlgren et al.
BRAIN (2020)
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Inger van Steenoven et al.
MOLECULAR NEURODEGENERATION (2020)
Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution
Tanis J. Ferman et al.
NEUROLOGY (2020)
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
Lana M. Chahine et al.
NEUROLOGY (2020)
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
C. Delaby et al.
SCIENTIFIC REPORTS (2020)
Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results
Ningshan Wang et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue from Parkinson's Disease Patients
Sireesha Manne et al.
MOVEMENT DISORDERS (2020)
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
Daniel Ferreira et al.
NEUROLOGY (2020)
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
Jennifer G. Goldman et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Tau pathology associates with in vivo cortical thinning in Lewy body disorders
Nicola Spotorno et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An I-123-FP-CIT SPECT study
J. J. van der Zande et al.
NEUROIMAGE-CLINICAL (2020)
Seeding variability of different alpha synuclein strains in synucleinopathies
Niccolo Candelise et al.
ANNALS OF NEUROLOGY (2019)
Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
Sireesha Manne et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)
Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
Un Jung Kang et al.
MOVEMENT DISORDERS (2019)
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Alberto Lleo et al.
ALZHEIMERS & DEMENTIA (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Claire Bridel et al.
JAMA NEUROLOGY (2019)
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2019)
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Marie-Laure Arotcarena et al.
CELLS (2019)
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Inger van Steenoven et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients
Elena Antelmi et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Inger van Steenoven et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
David Coughlin et al.
ANNALS OF NEUROLOGY (2019)
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
Matilde Bongianni et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Alpha-Synudein in Skin Nerve Fibers as a Biomarker for Alpha-Synudeinopathies
Jee Young Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2019)
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
Jorge J. Llibre-Guerra et al.
JAMA NETWORK OPEN (2019)
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders
David J. Irwin et al.
NEUROLOGY (2018)
Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes
Chin-Hsien Lin et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
EEG Characteristics of Dementia With Lewy Bodies, Alzheimer's Disease and Mixed Pathology
Jessica J. van der Zande et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
Bradley R. Groveman et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Does Parkinson's disease start in the gut?
Arthur Lionnet et al.
ACTA NEUROPATHOLOGICA (2018)
Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies
A. W. Lemstra et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis
Xiaohui Hu et al.
NEUROLOGICAL SCIENCES (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
Mohammad Shahnawaz et al.
JAMA NEUROLOGY (2017)
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
Inger Van Steenoven et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
Carla Abdelnour et al.
MOVEMENT DISORDERS (2016)
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
Sara Hall et al.
MOVEMENT DISORDERS (2016)
The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease
Christopher H. Gibbons et al.
NEUROLOGY (2016)
Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects
Thomas G. Beach et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
Henrik Zetterberg et al.
JAMA NEUROLOGY (2016)
Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
Graham Fairfoul et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Retromer in Alzheimer disease, Parkinson disease and other neurological disorders
Scott A. Small et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
Courtney L. Sutphen et al.
JAMA NEUROLOGY (2015)
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleo et al.
NATURE REVIEWS NEUROLOGY (2015)
Concomitant pathologies among a spectrum of parkinsonian disorders
Brittany N. Dugger et al.
PARKINSONISM & RELATED DISORDERS (2014)
Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2013)
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Jing L. Guo et al.
CELL (2013)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study
Nicolas Villain et al.
BRAIN (2012)
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies
Jonathan Graff-Radford et al.
BRAIN (2012)
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
Ezra Mulugeta et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
分享论文
